跳至主要内容
临床试验/NCT01997138
NCT01997138撤回4 期

Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy -a Double Blind, Placebo Controlled Study Using Microdialysis Technique

Oslo University Hospital1 个研究点 分布在 1 个国家开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
Pain relief

研究概览

简要总结

This project investigates the relation between acute pain and local inflammation. Pain reported by the patients for knee arthroscopy are compared with local changes in inflammatory mediators by using microdialysis technique. Patients with moderate-to-severe pain are included in a randomized placebo-controlled trial of anakinra given intra-articularly.

详细描述

The effects of the recombinant IL-1 receptor antagonist anakinra both on acute pain and post operative inflammation will be evaluated. On inclusion, pain intensity will be measured on a five-point verbal rating scale (0= no pain, 1=mild pain, 2=moderate pain, 3=severe pain, and 4=intolerable pain), and on a visual analogue scale (0-100mm). VAS scale will be repeated at 20, 40, 60, 80, 100, 120, 140, 160, 180 and 200 minutes after inclusion / intervention. The patients will also rate pain intensity during a 5 meters walk at 200 minutes (evoked pain). The patient will rate pain at rest and evoked pain 24, 48 and 72 h after intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Otherwise healthy patients (ASA 1 and 2) undergoing knee arthroscopy in general anaesthesia.
  • •Being informed about and willing to participate in the study -

排除标准

  • •Pregnancy or lactation. Fertile women will be asked if they may be pregnant, and offered a pregnancy test if there is doubt.
  • •Established osteoarthritis or synovitis
  • •Known intolerance to anakinra
  • •Kidney failure (Creatinine clearance <30ml/min)
  • •History of frequent infectious diseases or immunodeficiency
  • •Heart failure
  • •History of drug -or alcohol abuse
  • •Participation in other synchronous clinical trials
  • •Perioperative steroid treatment, perioperative paracetamol (12 hrs), NSAIDs (24 hrs) or COX2-inhibitors (48 hrs).
  • •Use of tourniquet for bloodless field
  • •Strong preoperative pain (VRS ≥3)
  • •Intolerable postoperative pain (VRS=4)

研究组 & 干预措施

Anakinra

Experimental

Anakinra 100 mg in 2 ml saline IA

干预措施: Anakinra 100 mg in 2 ml saline IA (Drug)

Placebo

Placebo Comparator

Saline 2 ml IA

干预措施: Anakinra 100 mg in 2 ml saline IA (Drug)

结局指标

主要结局

Pain relief

时间窗: 72h

Selv reported pain

次要结局

  • Resuce analgesic drug consumption(72h)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Leiv Arne Rosseland

Professor MD

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验